GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Total Assets

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Total Assets : $0.04 Mil (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Total Assets?

Pathfinder Cell Therapy's Total Assets for the quarter that ended in Sep. 2015 was $0.04 Mil.

Total Assets is connected with ROA %. Pathfinder Cell Therapy's annualized ROA % for the quarter that ended in Sep. 2015 was -2,627.27%. Total Assets is also linked to Revenue through Asset Turnover. Pathfinder Cell Therapy's Asset Turnover for the quarter that ended in Sep. 2015 was 0.00.


Pathfinder Cell Therapy Total Assets Historical Data

The historical data trend for Pathfinder Cell Therapy's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Total Assets Chart

Pathfinder Cell Therapy Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.64 0.36 0.16 0.11

Pathfinder Cell Therapy Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.11 0.09 0.05 0.04

Pathfinder Cell Therapy Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Pathfinder Cell Therapy's Total Assets for the fiscal year that ended in Dec. 2014 is calculated as

Total Assets=Total Equity (A: Dec. 2014 )+Total Liabilities (A: Dec. 2014 )
=-5.943+6.049
=0.11

Pathfinder Cell Therapy's Total Assets for the quarter that ended in Sep. 2015 is calculated as

Total Assets=Total Equity (Q: Sep. 2015 )+Total Liabilities (Q: Sep. 2015 )
=-6.73+6.769
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pathfinder Cell Therapy  (OTCPK:PFND) Total Assets Explanation

Total Assets is connected with ROA %.

Pathfinder Cell Therapy's annualized ROA % for the quarter that ended in Sep. 2015 is

ROA %=Net Income (Q: Sep. 2015 )/( (Total Assets (Q: Jun. 2015 )+Total Assets (Q: Sep. 2015 ))/ count )
=-1.156/( (0.049+0.039)/ 2 )
=-1.156/0.044
=-2,627.27 %

Note: The Net Income data used here is four times the quarterly (Sep. 2015) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Pathfinder Cell Therapy's Asset Turnover for the quarter that ended in Sep. 2015 is

Asset Turnover
=Revenue (Q: Sep. 2015 )/( (Total Assets (Q: Jun. 2015 )+Total Assets (Q: Sep. 2015 ))/ count )
=0/( (0.049+0.039)/ 2 )
=0/0.044
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Pathfinder Cell Therapy Total Assets Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Traded in Other Exchanges
N/A
Address
12 Bow Street, Cambridge, MA, USA, 02138
Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.
Executives
John J Alam director 130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks director 100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines